July 1, 2026 Experience FMC $400 million strategic investment from Tessenderlo Group We are advising FMC on the transaction
June 29, 2026 Experience Iridium Communications $8 billion sale to Rocket Lab We are advising Iridium on the transaction
June 16, 2026 Experience Sleep Number chapter 11 filing, DIP financing and stalking horse APA We are representing Sleep Number and its affiliates in their chapter 11 cases
June 9, 2026 Experience GSK $10.6 billion acquisition of Nuvalent We are advising GSK on the transaction
May 27, 2026 Experience newcleo combination with NewHold Investment Corp III and PIPE financing We are advising newcleo on the transaction with the SPAC
May 7, 2026 Experience Strategic Value Partners acquisition of majority stake in New Frontera We advised Strategic Value Partners on the transaction
May 7, 2026 Experience Cross Country Healthcare sale to Knox Lane We are advising Cross Country Healthcare on the transaction